Home › Canada › TSX stocks › WEED

Canopy Growth Corporation (TSX: WEED)

WEED trades on the Toronto Stock Exchange in Life Sciences, headquartered in Ontario. Numbers below come from the TMX issuer list, Yahoo Finance closes and the Bank of Canada rate, each with its source.

Close · October 14, 2026

C$1.03

-4.63% on the day

Market cap (C$)

C$537.4M

TMX list, September 30, 2026

Market cap (US$)

US$376.8M

Small cap at 1.4263 C$/US$

1-year return

-46.4%

-34.0% year to date

Issuer list, sector and C$ market cap: TMX Group TSX and TSXV listed companies, as of September 30, 2026. US$ figures convert C$ at 1.4263 C$ per US$, the Bank of Canada daily rate for October 14, 2026. Close and returns: Yahoo Finance daily closes for WEED.TO, last bar 2026-10-14, computed by Sophia Capital. Website: Wikidata.

Profile

Field	Value
Ticker	WEED on the Toronto Stock Exchange
Yahoo symbol	WEED.TO
Sector	Life Sciences, Cannabis
Headquarters	Ontario
Listed	2016-07-26
Listing type	TSXV Grad
Shares outstanding	423,171,316
Also listed on	NasdaqGS
Index membership	Not in an S&P/TSX index per the TMX list
SEC CIK	0001737927
Website	www.canopygrowth.com
US listing	CGC

Returns

Window	Return
1 day	-4.6%
1 week	-18.9%
1 month	-22.0%
3 months	-23.1%
6 months	-30.9%
Year to date	-34.0%
1 year	-46.4%
From 52-week high	-61.1%
52-week range	C$1.03 to C$2.65

Links

Search filings on SEDAR+TMX Money quote Yahoo Finance SEC EDGAR filings Company website Open in the app

SEDAR+ is linked for searching only; nothing on this page is taken from it.

Recent Canadian filings by type

214 documents in 10 types. Each title links to the document at its source.

Annual financial statements (1)

Document	Type	Filed
The audited consolidated Period 2025-03-31	Annual financial statements (8-K)	2025-12-15

Interim financial statements (1)

Document	Type	Filed
The unaudited condensed Period 2025-09-30	Interim financial statements (8-K)	2025-12-15

News release (20)

Document	Type	Filed
Canopy Growth Reports First Quarter Fiscal Year 2027 Financial Results; Delivers 13% Net Revenue Growth with Contributions from All Businesses Period 2026-06-30	News release (8-K)	2026-08-07
Canopy Growth Reports Fourth Quarter and Fiscal Year 2026 Financial Results; Delivers Q4 FY2026 Net Revenue Growth of 27% in Canada Medical Period 2026-03-31	News release (8-K)	2026-06-15
Press Release, dated May 15, 2026.	News release (8-K)	2026-05-15
Press Release, dated March 16,	News release (8-K)	2026-03-16

Management information circular / proxy (18)

Document	Type	Filed
DEFA14A	Proxy statement (DEFA14A)	2026-10-06
DEFA14A	Proxy statement (DEFA14A)	2026-09-25
DEFA14A	Proxy statement (DEFA14A)	2026-09-15
DEFA14A	Proxy statement (DEFA14A)	2026-08-17

Prospectus (7)

Document	Type	Filed
424B5	Prospectus supplement (424B5)	2025-08-29
424B5	Prospectus supplement (424B5)	2025-06-06
424B7	Prospectus supplement (424B7)	2025-06-06
424B5	Prospectus supplement (424B5)	2025-02-28

Annual report (2)

Document	Type	Filed
10-K Period 2026-03-31	Annual report (10-K) (10-K)	2026-06-15
10-K Period 2025-03-31	Annual report (10-K) (10-K)	2025-05-30

Quarterly report (6)

Document	Type	Filed
10-Q Period 2026-06-30	Quarterly report (10-Q) (10-Q)	2026-08-07
10-Q Period 2025-12-31	Quarterly report (10-Q) (10-Q)	2026-02-06
10-Q Period 2025-09-30	Quarterly report (10-Q) (10-Q)	2025-11-07
10-Q Period 2025-06-30	Quarterly report (10-Q) (10-Q)	2025-08-08

Insider report (58)

Document	Type	Filed
Form 3	Form 3 (3)	2025-10-14
Form 3	Form 3 (3)	2025-08-08
Form 3	Form 3 (3)	2025-07-11
Form 4	Form 4 (4)	2026-09-30

Certification (32)

Document	Type	Filed
EX-31.1 Period 2026-06-30	Certification (SOX 302/906) (10-Q)	2026-08-07
EX-31.2 Period 2026-06-30	Certification (SOX 302/906) (10-Q)	2026-08-07
EX-32.1 Period 2026-06-30	Certification (SOX 302/906) (10-Q)	2026-08-07
EX-32.2 Period 2026-06-30	Certification (SOX 302/906) (10-Q)	2026-08-07

Other (69)

Document	Type	Filed
FORM 8-K	Current report (8-K) (8-K)	2026-08-07
8-K	Current report (8-K) (8-K)	2026-08-07
8-K	Current report (8-K) (8-K)	2026-06-15
FORM 8-K	Current report (8-K) (8-K)	2026-05-27

Sources: SEC EDGAR filings (public records). Documents filed only on SEDAR+ are not copied here; search SEDAR+ for the full record.

Trading halts

Trading: the last notice, on 2026-04-22, was a resumption.

Notice	Action	Reason	Notice
2026-04-22 11:55:02 AM ET	Resumption	No reason stated	CIRO notice
2026-04-22 11:50:02 AM ET	Halt	Single Stock Circuit Breaker	CIRO notice
2025-12-18 3:11:16 PM ET	Resumption	No reason stated	CIRO notice
2025-12-18 3:06:16 PM ET	Halt	Single Stock Circuit Breaker	CIRO notice
2025-12-18 1:15:09 PM ET	Resumption	No reason stated	CIRO notice
2025-12-18 1:10:09 PM ET	Halt	Single-Stock Circuit Breaker	CIRO notice
2025-12-18 01:05:58 PM ET	Resumption	No reason stated	CIRO notice
2025-12-18 1:00:58 PM ET	Halt	Single Stock Circuit Breaker	CIRO notice
2025-10-15 12:54:34 PM ET	Resumption	No reason stated	CIRO notice
2025-10-15 12:49:34 PM ET	Halt	Single-Stock Circuit Breaker	CIRO notice

Source: Canadian Investment Regulatory Organization (CIRO), Halts/Resumptions newsroom, notices since 2024-10-15.

Upcoming events

No upcoming earnings date, call or meeting announced in the SEC filings and newswire releases we read.

Source: dates read from the company's SEC filings and newswire releases; each row links to the announcement.

Peers in Life Sciences

Ticker	Company	Exchange	Market cap (C$)	1 month	1 year
FRX	Fennec Pharmaceuticals Inc.	TSX	C$542.2M	-15.4%	+17.6%
ACB	Aurora Cannabis Inc.	TSX	C$365.4M	+11.9%	-20.0%
CPH	Cipher Pharmaceuticals Inc.	TSX	C$346.0M	-9.6%	-6.3%
EPRX	Eupraxia Pharmaceuticals Inc.	TSX	C$844.6M	-16.5%	+11.4%
EDT	Spectral Medical Inc.	TSX	C$335.9M	-14.0%	-20.7%

The app has the price chart, every filing, private raises and the full peer set for WEED.

Open in the app